News
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent liver condition to date, with an estimated global prevalence of 38%.1 The progressive and inflammatory stages of ...
5h
GlobalData on MSNTargeting energy expenditure: the next wave of obesity drugsBiotechs investigate mitochondria-targeting drugs to claim a share in the weight loss drug market dominated by GLP-1RAs.
When most veterinarians hear the term "stem cell therapy," their minds often go to autologous procedures – tissue harvested ...
As early humans spread from lush African forests into grasslands, their need for ready sources of energy led them to develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results